La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study

Identifieur interne : 000397 ( Main/Exploration ); précédent : 000396; suivant : 000398

Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study

Auteurs : Roberto Pinto [France] ; Philippe L'Hostis [France] ; Alain Patat [France] ; Marie-Claude Homery [France] ; Amílcar Falcão [France] ; Teresa Nunes [France] ; José-Francisco Rocha [France] ; Patrício Soares-Da-Silva [France]

Source :

RBID : Hal:hal-01278613

English descriptors

Abstract

Opicapone, a novel third-generation catechol-O-methyltransferase inhibitor for use as adjunctive therapy in levodopa-treated Parkinson's disease patients, was investigated on cardiac repolarization in healthy adult volunteers. This was a single-center, randomized, double-blind, placebo-controlled, open-label active-controlled, 4-period crossover study conducted in 64 subjects. In each period, subjects received a single oral dose of 50 mg opicapone, 800 mg opicapone, placebo, or 400 mg moxifloxacin and 24-hour 12-lead Holter monitoring was performed on day -1 (baseline) and after each single dose. After a single oral administrations of 50 and 800 mg opicapone, opicapone was the major entity in the circulation, with a median tmax of 1.5–2.0 hours. Opicapone was rapidly eliminated, with an elimination half-life of 1–2 hours. There was no clinically relevant effect of 50 and 800 mg opicapone versus placebo on cardiac depolarization or repolarization. All upper bounds of the 1-sided 95% confidence interval (CI) were below 10 milliseconds, confirming that opicapone has no QT-prolonging effect. Moxifloxacin caused an increase in the QTcI, with a lower bound of the 2-sided 95% CI always higher than 5 milliseconds, around the tmax of peak concentration, demonstrating assay sensitivity. In conclusion, administration of opicapone at therapeutic (50 mg) and supratherapeutic (800 mg) doses did not induce a clinically significant prolongation of the QTc interval

Url:
DOI: 10.1002/cpdd.188


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study</title>
<author>
<name sortKey="Pinto, Roberto" sort="Pinto, Roberto" uniqKey="Pinto R" first="Roberto" last="Pinto">Roberto Pinto</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-333495" status="INCOMING">
<orgName>Faculty of Medicine University of Porto</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="L Hostis, Philippe" sort="L Hostis, Philippe" uniqKey="L Hostis P" first="Philippe" last="L'Hostis">Philippe L'Hostis</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-192736" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<addrLine>rue Jean-Louis Bertrand Rennes</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.biotrial.com/</ref>
</desc>
<listRelation>
<relation active="#struct-302139" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-302139" type="direct">
<org type="institution" xml:id="struct-302139" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Patat, Alain" sort="Patat, Alain" uniqKey="Patat A" first="Alain" last="Patat">Alain Patat</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-192736" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<addrLine>rue Jean-Louis Bertrand Rennes</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.biotrial.com/</ref>
</desc>
<listRelation>
<relation active="#struct-302139" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-302139" type="direct">
<org type="institution" xml:id="struct-302139" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Homery, Marie Claude" sort="Homery, Marie Claude" uniqKey="Homery M" first="Marie-Claude" last="Homery">Marie-Claude Homery</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-192736" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<addrLine>rue Jean-Louis Bertrand Rennes</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.biotrial.com/</ref>
</desc>
<listRelation>
<relation active="#struct-302139" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-302139" type="direct">
<org type="institution" xml:id="struct-302139" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Falcao, Amilcar" sort="Falcao, Amilcar" uniqKey="Falcao A" first="Amílcar" last="Falcão">Amílcar Falcão</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-337141" status="INCOMING">
<orgName>Faculty of Pharamcy- university of Coimbra</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Nunes, Teresa" sort="Nunes, Teresa" uniqKey="Nunes T" first="Teresa" last="Nunes">Teresa Nunes</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-333495" status="INCOMING">
<orgName>Faculty of Medicine University of Porto</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Rocha, Jose Francisco" sort="Rocha, Jose Francisco" uniqKey="Rocha J" first="José-Francisco" last="Rocha">José-Francisco Rocha</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-333495" status="INCOMING">
<orgName>Faculty of Medicine University of Porto</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Soares Da Silva, Patricio" sort="Soares Da Silva, Patricio" uniqKey="Soares Da Silva P" first="Patrício" last="Soares-Da-Silva">Patrício Soares-Da-Silva</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-333495" status="INCOMING">
<orgName>Faculty of Medicine University of Porto</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01278613</idno>
<idno type="halId">hal-01278613</idno>
<idno type="halUri">https://hal-univ-rennes1.archives-ouvertes.fr/hal-01278613</idno>
<idno type="url">https://hal-univ-rennes1.archives-ouvertes.fr/hal-01278613</idno>
<idno type="doi">10.1002/cpdd.188</idno>
<date when="2015-11">2015-11</date>
<idno type="wicri:Area/Hal/Corpus">000407</idno>
<idno type="wicri:Area/Hal/Curation">000407</idno>
<idno type="wicri:Area/Hal/Checkpoint">000127</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000127</idno>
<idno type="wicri:Area/Main/Merge">000399</idno>
<idno type="wicri:Area/Main/Curation">000397</idno>
<idno type="wicri:Area/Main/Exploration">000397</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study</title>
<author>
<name sortKey="Pinto, Roberto" sort="Pinto, Roberto" uniqKey="Pinto R" first="Roberto" last="Pinto">Roberto Pinto</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-333495" status="INCOMING">
<orgName>Faculty of Medicine University of Porto</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="L Hostis, Philippe" sort="L Hostis, Philippe" uniqKey="L Hostis P" first="Philippe" last="L'Hostis">Philippe L'Hostis</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-192736" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<addrLine>rue Jean-Louis Bertrand Rennes</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.biotrial.com/</ref>
</desc>
<listRelation>
<relation active="#struct-302139" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-302139" type="direct">
<org type="institution" xml:id="struct-302139" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Patat, Alain" sort="Patat, Alain" uniqKey="Patat A" first="Alain" last="Patat">Alain Patat</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-192736" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<addrLine>rue Jean-Louis Bertrand Rennes</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.biotrial.com/</ref>
</desc>
<listRelation>
<relation active="#struct-302139" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-302139" type="direct">
<org type="institution" xml:id="struct-302139" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Homery, Marie Claude" sort="Homery, Marie Claude" uniqKey="Homery M" first="Marie-Claude" last="Homery">Marie-Claude Homery</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-192736" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<addrLine>rue Jean-Louis Bertrand Rennes</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.biotrial.com/</ref>
</desc>
<listRelation>
<relation active="#struct-302139" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-302139" type="direct">
<org type="institution" xml:id="struct-302139" status="VALID">
<orgName>Biotrial</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Falcao, Amilcar" sort="Falcao, Amilcar" uniqKey="Falcao A" first="Amílcar" last="Falcão">Amílcar Falcão</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-337141" status="INCOMING">
<orgName>Faculty of Pharamcy- university of Coimbra</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Nunes, Teresa" sort="Nunes, Teresa" uniqKey="Nunes T" first="Teresa" last="Nunes">Teresa Nunes</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-333495" status="INCOMING">
<orgName>Faculty of Medicine University of Porto</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Rocha, Jose Francisco" sort="Rocha, Jose Francisco" uniqKey="Rocha J" first="José-Francisco" last="Rocha">José-Francisco Rocha</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-333495" status="INCOMING">
<orgName>Faculty of Medicine University of Porto</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Soares Da Silva, Patricio" sort="Soares Da Silva, Patricio" uniqKey="Soares Da Silva P" first="Patrício" last="Soares-Da-Silva">Patrício Soares-Da-Silva</name>
<affiliation wicri:level="1">
<hal:affiliation type="institution" xml:id="struct-333495" status="INCOMING">
<orgName>Faculty of Medicine University of Porto</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1002/cpdd.188</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term> COMT inhibitors</term>
<term> QT</term>
<term> QTc</term>
<term> opicapone</term>
<term>cardiac repolarization</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Opicapone, a novel third-generation catechol-O-methyltransferase inhibitor for use as adjunctive therapy in levodopa-treated Parkinson's disease patients, was investigated on cardiac repolarization in healthy adult volunteers. This was a single-center, randomized, double-blind, placebo-controlled, open-label active-controlled, 4-period crossover study conducted in 64 subjects. In each period, subjects received a single oral dose of 50 mg opicapone, 800 mg opicapone, placebo, or 400 mg moxifloxacin and 24-hour 12-lead Holter monitoring was performed on day -1 (baseline) and after each single dose. After a single oral administrations of 50 and 800 mg opicapone, opicapone was the major entity in the circulation, with a median tmax of 1.5–2.0 hours. Opicapone was rapidly eliminated, with an elimination half-life of 1–2 hours. There was no clinically relevant effect of 50 and 800 mg opicapone versus placebo on cardiac depolarization or repolarization. All upper bounds of the 1-sided 95% confidence interval (CI) were below 10 milliseconds, confirming that opicapone has no QT-prolonging effect. Moxifloxacin caused an increase in the QTcI, with a lower bound of the 2-sided 95% CI always higher than 5 milliseconds, around the tmax of peak concentration, demonstrating assay sensitivity. In conclusion, administration of opicapone at therapeutic (50 mg) and supratherapeutic (800 mg) doses did not induce a clinically significant prolongation of the QTc interval</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Pinto, Roberto" sort="Pinto, Roberto" uniqKey="Pinto R" first="Roberto" last="Pinto">Roberto Pinto</name>
</noRegion>
<name sortKey="Falcao, Amilcar" sort="Falcao, Amilcar" uniqKey="Falcao A" first="Amílcar" last="Falcão">Amílcar Falcão</name>
<name sortKey="Homery, Marie Claude" sort="Homery, Marie Claude" uniqKey="Homery M" first="Marie-Claude" last="Homery">Marie-Claude Homery</name>
<name sortKey="L Hostis, Philippe" sort="L Hostis, Philippe" uniqKey="L Hostis P" first="Philippe" last="L'Hostis">Philippe L'Hostis</name>
<name sortKey="Nunes, Teresa" sort="Nunes, Teresa" uniqKey="Nunes T" first="Teresa" last="Nunes">Teresa Nunes</name>
<name sortKey="Patat, Alain" sort="Patat, Alain" uniqKey="Patat A" first="Alain" last="Patat">Alain Patat</name>
<name sortKey="Rocha, Jose Francisco" sort="Rocha, Jose Francisco" uniqKey="Rocha J" first="José-Francisco" last="Rocha">José-Francisco Rocha</name>
<name sortKey="Soares Da Silva, Patricio" sort="Soares Da Silva, Patricio" uniqKey="Soares Da Silva P" first="Patrício" last="Soares-Da-Silva">Patrício Soares-Da-Silva</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000397 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000397 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Hal:hal-01278613
   |texte=   Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024